Page last updated: 2024-08-18

pyrroles and Dermatitis Medicamentosa

pyrroles has been researched along with Dermatitis Medicamentosa in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	20 (42.55)	29.6817
2010's	24 (51.06)	24.3611
2020's	3 (6.38)	2.80

Authors

Authors	Studies
Fujiyama, T; Honda, T; Kurihara, K; Tokura, Y	1
Cauthon, KAB; Hanson, K; Mattes, RG	1
Abida, W; Brownstein, S; Drilon, A; Gounder, MM; Groover, A; Harding, JJ; Hyman, DM; Janku, F; Lacouture, ME; Lezcano, C; Li, BT; Liu, D; Offin, M; Sullivan, RJ; Torrisi, JM; Varterasian, M; Welsch, D; Wu, J	1
Ambrose, H; Bando, H; Banerji, U; Barrett, JC; Baselga, J; Bedard, PL; Berger, MF; Bouvier, N; Chandarlapaty, S; Chang, MT; Dean, EJ; Donoghue, MTA; Dougherty, B; El-Khoueiry, AB; Erinjeri, JP; Foxley, A; Hyman, DM; Lindemann, JPO; McEwen, R; Mita, A; Pass, M; Pérez-Fidalgo, JA; Reichel, JB; Schellens, JHM; Schiavon, G; Selcuklu, SD; Smyth, LM; Solit, DB; Soumerai, TE; Taylor, BS; Torrisi, J; Westin, SN	1
Alavi, A; Amiri, A; French, LE; Shear, NH; Wang, JY	1
Cranwell, WC; De Cruz, R; Doolan, BJ; Varigos, GA	1
Borrego, L; Hernández, N; Peñate, Y	1
Errihani, H; Kharmoum, S	1
Kabashima, K; Matsuda, A; Matsui, M; Matubara, K; Sasahashi, M; Ueharaguchi, Y	1
Albarrán-Planelles, C; Báez-Perea, JM; Jiménez-Gallo, D; Linares-Barrios, M; Martínez-Rodríguez, A	1
Derbel Miled, O; Dionne, C; Droz, JP; Flechon, A; Negrier, S; Neidhart, EM; Segura-Ferlay, C; Terret, C	1
Ara, M; Pastushenko, E	1
Guillén, C; Llombart, B; Martorell-Calatayud, A; Nagore, E; Requena, C; Sanmartín, O; Sanz-Motilva, V; Serra-Guillén, C; Traves, V	1
Abdel-Rahman, O; Fouad, M	1
Sommer, M; Stoevesandt, J; Trautmann, A	1
Carreño-Rojo, A; Chica-Marchal, A; Huertas, AJ; Mérida-Fernández, C; Ramírez-Hernández, M	1
Baggstrom, MQ; Baker, S; Crawford, JA; Edelman, MJ; Feliciano, J; Gu, L; Hahn, O; Novotny, P; Socinski, MA; Stinchcombe, TE; Vokes, EE; Wang, XF	1
Ramot, Y; Shreberk-Hassidim, R; Zlotogorski, A	1
Berneburg, M; Guenova, E; Hoetzenecker, W; Metzler, G; Mitev, V; Röcken, M; Voykov, B; Weber, HO	1
Barete, S; Billemont, B; Rixe, O	1
Boone, SL; Jameson, G; Lacouture, ME; Von Hoff, D	1
Dubertret, L; Gressier, L; Pruvost-Balland, C; Viguier, M	1
Bukowski, RM	1
Chu, D; Lacouture, ME; Weiner, E; Wu, S	1
Curiel, RE; Motzer, RJ; Patel, PH; Senico, PL	1
Behnam, SE; Fife, DJ; Linden, KG; Wu, JJ	1
Chang, SE; Choi, JH; Kang, YK; Koh, JK; Lee, JL; Lee, MW; Lee, WJ; Moon, KC	1
Carbonell, CE; Coleman, TA; Davis, CH; Davis, WB; La Vine, DB	1
Lipworth, AD; Robert, C; Zhu, AX	1
Wood, LS	1
Eames, T; Staehler, M; Wollenberg, A	1
Barbaud, A; Cuny, JF; Granel-Brocard, F; Guyot-Caquelin, P; Marchal, A; Schmutz, JL; Spaeth, D; Trechot, P	1
Bednaríková, D; Kocák, I	1
Guillén, C; Martorell-Calatayud, A; Sanmartín, O; Traves-Zapata, V	1
Budak, K; Pestalozzi, B; Weisshaupt, Ch	1
Chevreau, C; Cottura, E; Garrido-Stowhas, I; Sibaud, V	1
Eisen, T; Escudier, B; Izzedine, H; Mulders, P; Pyle, L; Robert, C; Sternberg, CN; Zbinden, S	1
Haseke, N; Heinemann, G; Schöppler, G; Stadler, T; Staehler, M; Stief, CG	1
Robert, C	1
Berg, BC; Chow, S; Suwattee, P; Warshaw, EM	1
Kuzel, T; Lacouture, ME; Newman, MA; Rosenbaum, SE; West, DP; Wu, S	1
Autier, J; Mateus, C; Robert, C; Spatz, A; Wechsler, J	1
Chevreau, C; Delord, JP; Deslandres, M; Sibaud, V	1
Burgin, S; Heidary, N; Naik, H	1
Feldmann, J; Jurcsik, A; Kopcsányi, H; Péch, Z	1
Dolfus, A; Faivre, M; Lipsker, D	1
Eickert, A; Hunzelmann, N; König, C; Krieg, T; Scharfetter-Kochanek, K	1

Reviews

17 review(s) available for pyrroles and Dermatitis Medicamentosa

Article	Year
Drug-Induced Pyoderma Gangrenosum: A Review. American journal of clinical dermatology, 2018, Volume: 19, Issue:1 Topics: Cocaine; Drug Eruptions; Humans; Immunosuppressive Agents; Indoles; Isotretinoin; Propylthiouracil; Pyoderma Gangrenosum; Pyrroles; Sunitinib; Tumor Necrosis Factor-alpha; Withholding Treatment	2018
Antiangiogenic agents and the skin: cutaneous adverse effects of sorafenib, sunitinib, and bevacizumab. Actas dermo-sifiliograficas, 2014, Volume: 105, Issue:10 Topics: Administration, Cutaneous; Angiogenesis Inhibitors; Antineoplastic Agents; Bevacizumab; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Humans; Indoles; Niacinamide; Phenylurea Compounds; Pyrroles; Sorafenib; Sunitinib	2014
Risk of mucocutaneous toxicities in patients with solid tumors treated with sunitinib: a critical review and meta analysis. Expert review of anticancer therapy, 2015, Volume: 15, Issue:1 Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Eruptions; Hand-Foot Syndrome; Humans; Indoles; Mucositis; Pyrroles; Sunitinib	2015
Janus kinase inhibitors in dermatology: A systematic review. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:4 Topics: Alopecia Areata; Anti-Inflammatory Agents; Antineoplastic Agents; Azetidines; Dermatologic Agents; Drug Eruptions; Humans; Janus Kinases; Molecular Targeted Therapy; Nitriles; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Signal Transduction; Skin Diseases; Sulfonamides	2017
Risk of hand-foot skin reaction with the multitargeted kinase inhibitor sunitinib in patients with renal cell and non-renal cell carcinoma: a meta-analysis. Clinical genitourinary cancer, 2009, Volume: 7, Issue:1 Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Drug Eruptions; Foot Diseases; Hand Dermatoses; Humans; Incidence; Indoles; Kidney Neoplasms; Paresthesia; Protein Kinase Inhibitors; Pyrroles; Risk Factors; Sunitinib	2009
Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib. Oncology, 2009, Volume: 77, Issue:5 Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Erythema; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Niacinamide; Paresthesia; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Risk Factors; Sorafenib; Sunitinib; Syndrome	2009
Management of vascular endothelial growth factor and multikinase inhibitor side effects. Clinical journal of oncology nursing, 2009, Volume: 13 Suppl Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Carcinoma, Renal Cell; Diarrhea; Drug Eruptions; Drug Monitoring; Fatigue; Humans; Indoles; Interleukin-2; Intracellular Signaling Peptides and Proteins; Kidney Neoplasms; Male; Niacinamide; Oncology Nursing; Phenylurea Compounds; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridines; Pyrroles; Sorafenib; Sunitinib; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A	2009
[Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2010, Volume: 61, Issue:8 Topics: Antineoplastic Agents; Benzenesulfonates; Drug Delivery Systems; Drug Eruptions; Humans; Indoles; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Structure-Activity Relationship; Sunitinib	2010
[Hand-foot syndrome after administration of tyrosinkinase inhibitors]. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2010, Volume: 23, Issue:5 Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Syndrome	2010
[Dermatologic side effects induced by new angiogenesis inhibitors]. Bulletin du cancer, 2011, Volume: 98, Issue:10 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Bevacizumab; Drug Eruptions; Humans; Indazoles; Indoles; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Piperidines; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Skin; Sorafenib; Sulfonamides; Sunitinib	2011
Targeted therapies for renal cell carcinoma: review of adverse event management strategies. Journal of the National Cancer Institute, 2012, Jan-18, Volume: 104, Issue:2 Topics: Anorexia; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Carcinoma, Renal Cell; Cardiovascular System; Drug Eruptions; Europe; Everolimus; Evidence-Based Medicine; Gastrointestinal Tract; Humans; Hypothyroidism; Indazoles; Indoles; Kidney Neoplasms; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pneumonia; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Sirolimus; Sorafenib; Sulfonamides; Sunitinib; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Weight Loss; Wound Healing	2012
[Managing the side effects of angiogenetic inhibitors in metastatic renal cell carcinoma]. Der Urologe. Ausg. A, 2006, Volume: 45, Issue:10 Topics: Adult; Angiogenesis Inhibitors; Benzenesulfonates; Carcinoma, Renal Cell; Drug Eruptions; Female; Gastrointestinal Diseases; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Sorafenib; Sunitinib; Treatment Outcome	2006
[Cutaneous side effects of antiangiogenic agents]. Bulletin du cancer, 2007, Volume: 94 Spec No Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Bevacizumab; Drug Eruptions; Humans; Indoles; Niacinamide; Phenylurea Compounds; Pigmentation Disorders; Pyridines; Pyrroles; Skin Diseases; Sorafenib; Sunitinib	2007
Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2008, Volume: 16, Issue:6 Topics: Angiogenesis Inhibitors; Drug Eruptions; Humans; Incidence; Indoles; Protein-Tyrosine Kinases; Pyrroles; Quality of Life; Sunitinib	2008
[Cutaneous side effects of sorafenib and sunitinib]. Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:2 Topics: Acrodermatitis; Angiogenesis Inhibitors; Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Hair Diseases; Humans; Indoles; Nail Diseases; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; raf Kinases; Receptors, Vascular Endothelial Growth Factor; Skin; Sorafenib; Sunitinib	2008
[Cutaneous side effects associated with epidermal growth factor receptor and tyrosine kinase inhibitors]. Annales de dermatologie et de venereologie, 2008, Volume: Spec No 1 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Benzenesulfonates; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Humans; Imatinib Mesylate; Indoles; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Sorafenib; Sunitinib	2008
Chemotherapeutic agents and the skin: An update. Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites; Antineoplastic Agents; Benzamides; Benzenesulfonates; Cetuximab; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; ErbB Receptors; Erlotinib Hydrochloride; Fusion Proteins, bcr-abl; Gefitinib; Hair Diseases; Humans; Imatinib Mesylate; Indoles; Mucous Membrane; Nail Diseases; Niacinamide; Phenylurea Compounds; Piperazines; Platinum Compounds; Proteasome Inhibitors; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Signal Transduction; Skin; Skin Diseases; Sorafenib; Sunitinib; Taxoids	2008

Trials

3 trial(s) available for pyrroles and Dermatitis Medicamentosa

Article	Year
Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers. Investigational new drugs, 2021, Volume: 39, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Analgesics; Anti-Bacterial Agents; Antineoplastic Agents; Drug Eruptions; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Male; Middle Aged; Neoplasms; Protein Kinase Inhibitors; Pyrroles; Skin; Steroids; Young Adult	2021
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2017, Volume: 12, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Double-Blind Method; Drug Eruptions; Fatigue; Female; Humans; Hypertension; Indoles; Intention to Treat Analysis; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Mucositis; Neoplasm Staging; Neutropenia; Platinum Compounds; Pyrroles; Quality of Life; Sunitinib; Survival Rate; Thrombocytopenia	2017
Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma. Clinical genitourinary cancer, 2009, Volume: 7, Issue:1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cellulitis; Diarrhea; Drug Eruptions; Female; Humans; Indoles; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Sirolimus; Stomatitis; Sunitinib; Thrombocytopenia; Treatment Outcome	2009

Other Studies

27 other study(ies) available for pyrroles and Dermatitis Medicamentosa

Article	Year
Two cases of psoriasiform dermatitis arising during dupilumab therapy and successfully treated with delgocitinib ointment. European journal of dermatology : EJD, 2021, Oct-01, Volume: 31, Issue:5 Topics: Administration, Topical; Adult; Antibodies, Monoclonal, Humanized; Dermatitis, Atopic; Dermatologic Agents; Drug Eruptions; Humans; Interleukin-4 Receptor alpha Subunit; Male; Ointments; Pyrroles; Treatment Outcome; Young Adult	2021
Drug Eruption From Atorvastatin: With Initial Misdiagnosis of The Senior care pharmacist, 2023, Feb-01, Volume: 38, Issue:2 Topics: Aged; Atorvastatin; Drug Eruptions; Drug Substitution; Exanthema; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Simvastatin; Tinea cruris	2023
AKT Inhibition in Solid Tumors With AKT1 Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Jul-10, Volume: 35, Issue:20 Topics: Adult; Aged; Alleles; Antineoplastic Agents; Biomarkers, Tumor; Diarrhea; Disease-Free Survival; DNA, Neoplasm; Drug Eruptions; Exanthema; Female; Humans; Hyperglycemia; Loss of Heterozygosity; Male; Middle Aged; Mutation; Neoplasms; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Response Evaluation Criteria in Solid Tumors; Signal Transduction	2017
An urticarial drug eruption caused by tofacitinib for alopecia universalis. Dermatologic therapy, 2019, Volume: 32, Issue:4 Topics: Alopecia; Drug Eruptions; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Urticaria; Young Adult	2019
Generalized erythematous-violaceous plaques in a patient with a history of dyslipidemia. Interstitial granulomatous drug reaction (IGDR). International journal of dermatology, 2013, Volume: 52, Issue:4 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Drug Eruptions; Dyslipidemias; Erythema; Female; Granuloma; Heptanoic Acids; Humans; Pyrroles	2013
Erosive nappy erythema following sunitinib intake. The Pan African medical journal, 2013, Volume: 14 Topics: Antineoplastic Agents; Buttocks; Drug Eruptions; Erythema; Humans; Indoles; Male; Middle Aged; Pyrroles; Scrotum; Sunitinib	2013
A case of pyoderma gangrenosum possibly associated with sunitinib treatment. International journal of dermatology, 2013, Volume: 52, Issue:5 Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Eruptions; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Prednisone; Pyoderma Gangrenosum; Pyrroles; Sunitinib	2013
Eruptive melanocytic nevi in a patient undergoing treatment with sunitinib. JAMA dermatology, 2013, Volume: 149, Issue:5 Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Drug Eruptions; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Nevus, Pigmented; Pyrroles; Sunitinib	2013
Sorafenib and sunitinib for elderly patients with renal cell carcinoma. Journal of geriatric oncology, 2013, Volume: 4, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Asthenia; Carcinoma, Renal Cell; Disease-Free Survival; Drug Eruptions; Female; Humans; Indoles; Kidney Neoplasms; Male; Neutropenia; Niacinamide; Phenylurea Compounds; Pyrroles; Retrospective Studies; Sorafenib; Sunitinib; Treatment Outcome	2013
Sunitinib-induced pseudoporphyria. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:9 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Diagnosis, Differential; Drug Eruptions; Gastrointestinal Stromal Tumors; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Porphyrias; Pyrroles; Sunitinib	2015
Relief of photoallergy: atorvastatin replacing simvastatin. Journal of investigational allergology & clinical immunology, 2015, Volume: 25, Issue:2 Topics: Atorvastatin; Dermatitis, Photoallergic; Drug Eruptions; Drug Substitution; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Tests; Male; Predictive Value of Tests; Pyrroles; Risk Factors; Simvastatin; Treatment Outcome	2015
Fixed drug eruption due to atorvastatin. Journal of investigational allergology & clinical immunology, 2015, Volume: 25, Issue:2 Topics: Aged, 80 and over; Atorvastatin; Drug Eruptions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Patch Tests; Predictive Value of Tests; Pyrroles; Recurrence; Risk Factors	2015
Palmar-plantar erythrodysesthesia secondary to sunitinib treatment resulting in necrotic foot syndrome aggravated by background diabetic vascular disease. Archives of dermatology, 2008, Volume: 144, Issue:8 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Diabetic Angiopathies; Drug Eruptions; Foot; Foot Diseases; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Necrosis; Paresthesia; Pyrroles; Skin; Sunitinib	2008
Scrotal cutaneous side effects of sunitinib. The New England journal of medicine, 2008, Aug-28, Volume: 359, Issue:9 Topics: Antineoplastic Agents; Drug Eruptions; Genital Diseases, Male; Humans; Indoles; Male; Pyrroles; Scrotum; Sunitinib	2008
Blackberry-induced hand-foot skin reaction to sunitinib. Investigational new drugs, 2009, Volume: 27, Issue:4 Topics: Antineoplastic Agents; Cell Phone; Colorectal Neoplasms; Drug Eruptions; Female; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Middle Aged; Pyrroles; Sunitinib	2009
[Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)]. Annales de dermatologie et de venereologie, 2009, Volume: 136, Issue:1 Topics: Abdominal Pain; Arthralgia; Atorvastatin; Diarrhea; Drug Eruptions; Eosinophilia; Facial Dermatoses; Female; Fever; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pyrroles	2009
Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigm. Clinical genitourinary cancer, 2009, Volume: 7, Issue:1 Topics: Benzenesulfonates; Carcinoma, Renal Cell; Drug Eruptions; Foot Diseases; Hand Dermatoses; Humans; Indoles; Kidney Neoplasms; Niacinamide; Paresthesia; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrroles; Sorafenib; Sunitinib	2009
Sunitinib-induced hand-foot syndrome: a new, distinct form. Clinical and experimental dermatology, 2010, Volume: 35, Issue:2 Topics: Aged; Antineoplastic Agents; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Male; Pyrroles; Sunitinib; Syndrome	2010
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. The British journal of dermatology, 2009, Volume: 161, Issue:5 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Drug Eruptions; Female; Foot Dermatoses; Gastrointestinal Stromal Tumors; Hand Dermatoses; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Retrospective Studies; Skin Diseases; Sorafenib; Stomatitis; Sunitinib; Young Adult	2009
Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma. American journal of clinical oncology, 2010, Volume: 33, Issue:3 Topics: Administration, Oral; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Disease Progression; Drug Administration Schedule; Drug Eruptions; Female; Humans; Hypertension; Hypothyroidism; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Retrospective Studies; Sorafenib; Sunitinib	2010
[Leg ulcerations and sunitinib]. Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:10 Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Eruptions; Female; Humans; Indoles; Kidney Neoplasms; Leg Ulcer; Liver Neoplasms; Lung Neoplasms; Pyrroles; Risk Factors; Sarcoma; Sunitinib; Venous Thrombosis	2010
[Gottron-like papules induced by sunitinib]. Actas dermo-sifiliograficas, 2011, Volume: 102, Issue:5 Topics: Aged; Antineoplastic Agents; Drug Eruptions; Humans; Indoles; Male; Pyrroles; Skin Diseases, Papulosquamous; Sunitinib	2011
[Adverse effects of new oncologic therapies]. Praxis, 2011, Jul-27, Volume: 100, Issue:15 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Cetuximab; Colonic Neoplasms; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Everolimus; Facial Dermatoses; Humans; Indoles; Liver Neoplasms; Male; Middle Aged; Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Quinazolines; Sirolimus; Sorafenib; Sunitinib; Trastuzumab	2011
Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis. Archives of dermatology, 2008, Volume: 144, Issue:1 Topics: Antineoplastic Agents; Carcinoid Tumor; Drug Eruptions; Erythema; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Immunosuppressive Agents; Indoles; Male; Middle Aged; Mouth Mucosa; Mucositis; Pyrroles; Risk Assessment; Skin Diseases, Vesiculobullous; Sunitinib; Treatment Outcome	2008
[Difficulties in detecting the causative agent of an adverse drug reaction in a complicated case]. Orvosi hetilap, 2008, May-11, Volume: 149, Issue:19 Topics: Administration, Cutaneous; Administration, Oral; Anticonvulsants; Antidepressive Agents; Atorvastatin; Azabicyclo Compounds; Drug Eruptions; Female; Heptanoic Acids; Humans; Lamotrigine; Middle Aged; Piperazines; Pyrroles; Risperidone; Sertraline; Skin Tests; Triazines	2008
[Lymphocyte infiltration in superficial dermis]. Annales de dermatologie et de venereologie, 2001, Volume: 128, Issue:1 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Drug Eruptions; Heptanoic Acids; Humans; Lymphocytes; Male; Pyrroles	2001
Linear IgA bullous dermatosis induced by atorvastatin. Journal of the American Academy of Dermatology, 2001, Volume: 44, Issue:4 Topics: Anticholesteremic Agents; Atorvastatin; Drug Eruptions; Heptanoic Acids; Humans; Immunoglobulin A; Male; Middle Aged; Pyrroles; Skin Diseases, Vesiculobullous	2001